INDIANAPOLIS, Aug. 31 /PRNewswire/ -- Polymer Technology Systems, Inc. has
recently introduced the revolutionary BioScanner 2000(TM) test system for the
complete management of diabetes and diabetic complications
( www.diabetes-testing.com ). The BioScanner 2000(TM) resembles a common
glucose meter in function, but the similarity ends there as the device can
also test for Cholesterol, Ketone, HDL, LDL, Triglycerides, Hemoglobin A1c
(Glycohemoglobin), MicroAlbumin and Creatinine.
With the release of the BioScanner 2000(TM), the benefits now available to
both Type 1 and Type II diabetics are substantial because they can now test
for other blood chemistries in the privacy of their homes -- not just glucose.
Furthermore, the CLIA waiver means that more physicians will be able to offer
testing in their own offices and provide immediate analysis and feedback to
their patients while the doctor is with the patient. The results of these
tests allow diabetes patients and physicians to significantly increase the
management of diabetes, and, therefore, reduce the risk of diabetes
complications such as amputation, blindness and coronary heart disease. More
tests are currently in development for the BioScanner 2000(TM) and will be
released to both the professional and home consumer markets in the near
future. Consumers can also purchase the BioScanner 2000(TM) on the internet
at the following address: www.diabetes-testing.com .
The numerous features of the BioScanner 2000(TM) include: multiple blood
chemistry testing, one-step testing with no timing, averaging for previous ten
tests, past fourteen and thirty days and storage of up to seven hundred test
results, automatic shut-off in two minutes from non-use of instrument,
automatic calibration with inserted MEMo chip (included with each strip
package), results in less than one minute and future test capability.
The BioScanner 2000(TM) test system currently has FDA clearances for
Glucose, Cholesterol, HDL Cholesterol and Ketone. Triglyceride test strips
have also been submitted for approval and tests for LDL Cholesterol will be
submitted this month. Creatinine, MicroAlbumin, Hemoglobin A1c, and ALT will
be submitted by year's end, 1999.
Polymer Technology Systems, Inc., is a privately owned company located on
the northwest side of Indianapolis. Incorporated in 1992, PTS delivers
leading edge, point of care diagnostics to the health care market catering to
both physicians' offices and the home consumer.
SOURCE Polymer Technology Systems, Inc.